› Forums › General Melanoma Community › ASCO 2021 – Leptomemingeal Disease
- This topic has 3 replies, 2 voices, and was last updated 2 years, 3 months ago by Anni.
- Post
-
- July 1, 2021 at 7:12 pm
Yet another tough spot for melanoma peeps – not that there are any easy ones!! Post includes new info out of ASCO and links to pertinent prior posts: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2021/07/asco-2021-lmd-leptomeningeal-disease-in.htmlHolding Rob and his dear Adriana in my heart today and always. – c
Viewing 1 reply thread
- Replies
-
-
- June 27, 2022 at 6:58 pm
Just found your message, Anni. Not sure if you meant to mark it private. Not sure how to respond “privately” so I hope this is okay. As my link in the report above notes – intrathecal – the delivery of medications directly into the spinal fluid space, often via a port – administration of various medications (often immunotherapy like ipi and/or nivo) have had some success in LMD. Needless to say it is a complicated process, so it is not readily available everywhere. However, there is this report from 2021 in the UK noting the administration of methotrexate via IT followed by systemic therapy with good result – Durable complete remission of leptomeningeal melanoma by intrathecal methotrexate maintained with systemic ipilimumabSo, I would be calling Future Medicine in London, to see if I could get additional info.
This agency may be helpful as well: Cancer Research UK
Hope that helps. Celeste
Viewing 1 reply thread
- You must be logged in to reply to this topic.